These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36735042)
1. Predictive model based on DCE-MRI and clinical features for the evaluation of pain response after stereotactic body radiotherapy in patients with spinal metastases. Chen Y; Wang Q; Zhou G; Liu K; Qin S; Zhao W; Xin P; Yuan H; Zhuang H; Lang N Eur Radiol; 2023 Jul; 33(7):4812-4821. PubMed ID: 36735042 [TBL] [Abstract][Full Text] [Related]
2. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases. Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017 [TBL] [Abstract][Full Text] [Related]
3. MRI feature-based radiomics models to predict treatment outcome after stereotactic body radiotherapy for spinal metastases. Chen Y; Qin S; Zhao W; Wang Q; Liu K; Xin P; Yuan H; Zhuang H; Lang N Insights Imaging; 2023 Oct; 14(1):169. PubMed ID: 37817044 [TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR; Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044 [TBL] [Abstract][Full Text] [Related]
5. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases. Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959 [TBL] [Abstract][Full Text] [Related]
7. Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective study. Vellayappan B; Cheong D; Singbal S; Tey J; Yang Soon Y; Nang Leong C; Wong A; Lwin S; Hung Lee C; Periasamy P; Lo S; Kumar N Radiol Oncol; 2022 Dec; 56(4):525-534. PubMed ID: 36503714 [TBL] [Abstract][Full Text] [Related]
8. Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study. Guckenberger M; Sweeney RA; Hawkins M; Belderbos J; Andratschke N; Ahmed M; Madani I; Mantel F; Steigerwald S; Flentje M Cancer; 2018 May; 124(9):2001-2009. PubMed ID: 29499073 [TBL] [Abstract][Full Text] [Related]
9. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials. Tao R; Bishop AJ; Brownlee Z; Allen PK; Settle SH; Chang EL; Wang X; Amini B; Tannir NM; Tatsui C; Rhines LD; Brown PD; Ghia AJ Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1405-1413. PubMed ID: 27209509 [TBL] [Abstract][Full Text] [Related]
11. Proposing a quantitative MRI-based linear measurement framework for response assessment following stereotactic body radiation therapy in patients with spinal metastasis. Jabehdar Maralani P; Chen H; Moazen B; Mojtahed Zadeh M; Salehi F; Chan A; Zeng LK; Abugharib A; Tseng CL; Husain Z; Myrehaug S; Soliman H; Detsky J; Heyn C; Ruschin M; Larouche J; Sahgal A J Neurooncol; 2022 Oct; 160(1):265-272. PubMed ID: 36203028 [TBL] [Abstract][Full Text] [Related]
12. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054 [TBL] [Abstract][Full Text] [Related]
13. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system. Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620 [TBL] [Abstract][Full Text] [Related]
14. Postoperative re-irradiation using stereotactic body radiotherapy for metastatic epidural spinal cord compression. Ito K; Nihei K; Shimizuguchi T; Ogawa H; Furuya T; Sugita S; Hozumi T; ; Karasawa K J Neurosurg Spine; 2018 Sep; 29(3):332-338. PubMed ID: 29905524 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study. Mantel F; Sweeney RA; Klement RJ; Hawkins MA; Belderbos J; Ahmed M; Toussaint A; Polat B; Flentje M; Guckenberger M Radiother Oncol; 2019 Dec; 141():62-66. PubMed ID: 31526672 [TBL] [Abstract][Full Text] [Related]
16. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628 [TBL] [Abstract][Full Text] [Related]
17. Use of dynamic contrast-enhanced MRI for the early assessment of outcome of CyberKnife stereotactic radiosurgery for patients with spinal metastases. Chen Y; Zhang E; Wang Q; Yuan H; Zhuang H; Lang N Clin Radiol; 2021 Nov; 76(11):864.e1-864.e6. PubMed ID: 34404514 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT? Park HJ; Kim HJ; Won JH; Lee SC; Chang AR Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases. Guckenberger M; Mantel F; Sweeney RA; Hawkins M; Belderbos J; Ahmed M; Andratschke N; Madani I; Flentje M Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):348-357. PubMed ID: 33412262 [TBL] [Abstract][Full Text] [Related]
20. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. Boehling NS; Grosshans DR; Allen PK; McAleer MF; Burton AW; Azeem S; Rhines LD; Chang EL J Neurosurg Spine; 2012 Apr; 16(4):379-86. PubMed ID: 22225488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]